Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


aop.org.uk > ot > features > 10/12/2026 > innovation-in-action-how-new-glp1s-new-treatments-and-ai-are-changing-ophthalmology

Innovation in action: how new GLP-1s, new treatments and AI are changing ophthalmology

19+ min ago   (410+ words) Three Moorfields Private consultants reflect on three changing areas of eye care Advertorial content is paid for and produced by a sponsor, and is reviewed and edited by the OT team before publication. Advances in ophthalmology are creating new opportunities…...


koreabiomed.com > news > articleView.html

[Interview] Covid-19 poses greater threat than flu, yet fewer Koreans get vaccinated: expert

3+ hour, 58+ min ago   (1186+ words) Covid-19 may no longer be a pandemic, but it continues to pose a greater risk of severe illness and death than influenza, particularly among older adults and immunocompromised patients, according to a Korean infectious disease specialist. Yet vaccination rates among…...


grafa.com > en > news > australia > acrux-secures-fda-phase-3-pathway-approval

Acrux secures FDA Phase 3 pathway approval

2+ hour, 55+ min ago   (225+ words) Assets related to this article Acrux (ASX:ACR) has secured a confirmed Phase 3 regulatory pathway from the U.S. Food and Drug Administration for its female testosterone metered-dose transdermal spray targeting hypoactive sexual desire disorder. The agreement follows an end-of-Phase 2 meeting with…...


actionnewsjax.com > news > trending > retatrutide-new-drug-shows-weight-loss-promise > 2M7FYPWPOVHZPAB4K6E6J7GH34

Retatrutide: New drug shows weight loss promise

18+ min ago   (324+ words) Another drug may soon hit the market to help battle obesity. Retatrutide, made by Eli Lilly, is a GLP-1 that, according to a new trial published in The Lancet this week, helped people with Type 2 diabetes lose up to 60 pounds…...


streamlinefeed.co.ke > news > gamgee-raises-4m-to-test-personalised-dog-cancer-vaccines

Gamgee Raises $4m to Test Personalised Dog Cancer Vaccines

31+ min ago   (648+ words) The Australian startup is recruiting dogs for an investigational mRNA trial; its origin story rests on one animal, not proof of clinical efficacy. An Australian startup is turning one dog’s experimental cancer treatment into a clinical program, but its new…...


medicaldaily.com > gut-bacteria-flagellin-vaccine-fever-science-study-479838

Gut Bacteria Protein Linked to Fever After COVID Vaccines in 171 Adults as Mouse Tests Point to Diet

6+ hour, 27+ min ago   (814+ words) Why do some people spend the day after a vaccine on the couch with a fever while others feel nothing? A new study in the journal Science points to an unexpected factor: a protein made by certain gut bacteria. Researchers…...


vietnam.vn > en > vnvc-no-luc-tiem-hon-100-000-lieu-vac-xin-phong-benh-tay-chan-mieng-cho-tre-sau-nua-thang

VNVC strives to administer over 100,000 doses of hand, foot, and mouth disease vaccine to children in half a month.

2+ hour, 9+ min ago   (507+ words) Amidst the peak season for hand, foot, and mouth disease, with many localities reporting severe cases and complications, the VNVC Vaccination System has administered over 100,000 doses of vaccine to children in just over half a month of implementation, while also…...


marketscreener.com > news > advicenne-decides-to-withdraw-its-adv7103-new-drug-application-in-the-usa-ce7858dcdf80f523

Advicenne Decides To Withdraw Its ADV7103 New Drug Application In The USA

2+ day, 14+ hour ago   (124+ words) Advicenne announced the voluntary withdrawal of the New Drug Application for ADV7103 in the treatment of primary distal Renal Tubular Acidosis in the USA. During the review process and ongoing... Advicenne announced the voluntary withdrawal of the New Drug Application (NDA)…...


marketscreener.com > news > advicenne-s-distal-renal-tubular-acidosis-medicine-secures-reimbursement-in-spain-ce7f51dbde8bf326

Advicenne's Distal Renal Tubular Acidosis Medicine Secures Reimbursement in Spain

2+ day, 14+ hour ago   (52+ words) Advicenne said Monday the Spanish health authorities approved the reimbursement of Sibnayal, a prescription medicine to treat distal renal tubular acidosis. The specialty pharmaceutical company... Published on 07/21/2026 at 01:14 am EDT OHB and Soitec ride supportive news flow, Advicenne tumbles August…...


stocktwits.com > news-articles > markets > equity > ibrx-stock-declines-immunitybio-resubmits-anktiva-application-to-fda > cZdVj9URIIL

IBRX Stock Declines — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data

8+ hour, 52+ min ago   (394+ words) ImmunityBio Inc. (IBRX) on Monday announced that it has resubmitted the supplemental biologics license application (BLA) to the U.S. Food and Drug Administration for Anktiva. ImmunityBio stated that the application includes additional information requested by the FDA to support its supplemental…...